Insider Trading History of Baynes Roy D.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Baynes Roy D. since 2020. This trader's CIK number is 1680739. At the time of last reporting, Baynes Roy D. was the Officer of Travere Therapeutics, Inc.. (stock ticker symbol TVTX). Also see all insider trading activities at Travere Therapeutics, Inc..

Note that in the past Baynes Roy D. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Travere Therapeutics, Inc. (TVTX) by Baynes Roy D.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 TVTX 0 $0 26,000 $540,000 26,000 $454,400

Yearly summary of insider trading at Natera, Inc. (NTRA) by Baynes Roy D.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 NTRA 0 $0 37,230 $5,471,283 37,230 $879,558
2023 NTRA 0 $0 0 $0 3,534 $0
2022 NTRA 0 $0 0 $0 1,307 $0
2020 NTRA 0 $0 1,300 $69,513 1,300 $31,746


Insider trading activities at 2 companies by Baynes Roy D.:

1. Travere Therapeutics, Inc. (TVTX)

2. Natera, Inc. (NTRA)

Table 1. Insider trading of Travere Therapeutics, Inc. (TVTX) by Baynes Roy D.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-02-06 TVTX Option Ex 10,000 17.44 174,400
2025-02-06 TVTX Sale 10,000 22.00 220,000
2025-01-23 TVTX Option Ex 16,000 17.50 280,000
2025-01-23 TVTX Sale 16,000 20.00 320,000

Table 2. Insider trading of Natera, Inc. (NTRA) by Baynes Roy D.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-11-15 NTRA Option Ex 37,230 23.62 879,558
2024-11-15 NTRA Sale 37,230 146.96 5,471,283
2023-05-25 NTRA Option Ex 3,534 .00 0
2022-05-25 NTRA Option Ex 1,307 .00 0
2020-08-07 NTRA Option Ex 1,300 24.42 31,746
2020-08-07 NTRA Sale 1,300 53.47 69,513

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Baynes Roy D. (Officer of Travere Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.